Cross Country Healthcare, Inc. (CCRN)
USD 13.61
(0.59%)
USD 13.61
(0.59%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 72.63 Million USD | -61.46% |
| 2022 | 188.46 Million USD | 42.77% |
| 2021 | 132 Million USD | 1187.15% |
| 2020 | -12.14 Million USD | 78.3% |
| 2019 | -55.94 Million USD | -230.03% |
| 2018 | -16.95 Million USD | -145.19% |
| 2017 | 37.51 Million USD | 370.85% |
| 2016 | 7.96 Million USD | 80.33% |
| 2015 | 4.41 Million USD | 113.9% |
| 2014 | -31.78 Million USD | 8.1% |
| 2013 | -34.58 Million USD | 18.09% |
| 2012 | -42.22 Million USD | -1130.28% |
| 2011 | 4.09 Million USD | 247.68% |
| 2010 | -2.77 Million USD | -141.46% |
| 2009 | 6.69 Million USD | 104.68% |
| 2008 | -142.94 Million USD | -681.56% |
| 2007 | 24.57 Million USD | 47.75% |
| 2006 | 16.63 Million USD | 12.77% |
| 2005 | 14.75 Million USD | -28.59% |
| 2004 | 20.65 Million USD | -19.99% |
| 2003 | 25.82 Million USD | -13.3% |
| 2002 | 29.78 Million USD | 243.43% |
| 2001 | 8.67 Million USD | 88.6% |
| 2000 | 4.59 Million USD | -60.17% |
| 1999 | 11.54 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -16.05 Million USD | -696.21% |
| 2024 Q1 | 2.69 Million USD | -70.21% |
| 2023 Q4 | 9.03 Million USD | -29.46% |
| 2023 Q3 | 12.81 Million USD | -39.98% |
| 2023 FY | 72.63 Million USD | -61.46% |
| 2023 Q2 | 21.34 Million USD | -27.49% |
| 2023 Q1 | 29.43 Million USD | -24.12% |
| 2022 Q2 | 52.89 Million USD | -14.66% |
| 2022 FY | 188.46 Million USD | 42.77% |
| 2022 Q4 | 38.79 Million USD | 11.49% |
| 2022 Q3 | 34.79 Million USD | -34.22% |
| 2022 Q1 | 61.98 Million USD | -20.1% |
| 2021 Q2 | 11.54 Million USD | -40.62% |
| 2021 Q1 | 19.44 Million USD | 321.68% |
| 2021 FY | 132 Million USD | 1187.15% |
| 2021 Q4 | 77.57 Million USD | 231.04% |
| 2021 Q3 | 23.43 Million USD | 102.92% |
| 2020 Q3 | -1.33 Million USD | 90.57% |
| 2020 Q2 | -14.15 Million USD | -577.41% |
| 2020 FY | -12.14 Million USD | 78.3% |
| 2020 Q4 | 4.61 Million USD | 445.73% |
| 2020 Q1 | -2.08 Million USD | -82.6% |
| 2019 FY | -55.94 Million USD | -230.03% |
| 2019 Q2 | -51.67 Million USD | -2824.39% |
| 2019 Q3 | -3.12 Million USD | 93.95% |
| 2019 Q4 | -1.14 Million USD | 63.43% |
| 2019 Q1 | -1.76 Million USD | 91.03% |
| 2018 Q3 | -441 Thousand USD | -128.65% |
| 2018 Q2 | 1.53 Million USD | -6.27% |
| 2018 FY | -16.95 Million USD | -145.19% |
| 2018 Q1 | 1.64 Million USD | -94.13% |
| 2018 Q4 | -19.69 Million USD | -4365.08% |
| 2017 Q1 | -2.01 Million USD | 74.51% |
| 2017 Q2 | 4.85 Million USD | 341.29% |
| 2017 FY | 37.51 Million USD | 370.85% |
| 2017 Q3 | 6.72 Million USD | 38.62% |
| 2017 Q4 | 27.95 Million USD | 315.74% |
| 2016 Q4 | -7.88 Million USD | -156.05% |
| 2016 FY | 7.96 Million USD | 80.33% |
| 2016 Q3 | 14.06 Million USD | 181.6% |
| 2016 Q1 | 19.02 Million USD | 411.94% |
| 2016 Q2 | -17.23 Million USD | -190.62% |
| 2015 Q4 | -6.09 Million USD | -221.74% |
| 2015 Q3 | 5 Million USD | 94.68% |
| 2015 FY | 4.41 Million USD | 113.9% |
| 2015 Q1 | 2.93 Million USD | 114.51% |
| 2015 Q2 | 2.57 Million USD | -12.3% |
| 2014 Q1 | -782 Thousand USD | 97.78% |
| 2014 FY | -31.78 Million USD | 8.1% |
| 2014 Q4 | -20.21 Million USD | -165.96% |
| 2014 Q3 | -7.6 Million USD | -138.98% |
| 2014 Q2 | -3.18 Million USD | -306.78% |
| 2013 Q2 | -1.45 Million USD | -225.82% |
| 2013 Q3 | 914 Thousand USD | 162.73% |
| 2013 Q4 | -35.2 Million USD | -3951.2% |
| 2013 FY | -34.58 Million USD | 18.09% |
| 2013 Q1 | 1.15 Million USD | 112.15% |
| 2012 Q2 | -14.5 Million USD | -2383.56% |
| 2012 Q3 | -17.6 Million USD | -21.35% |
| 2012 Q4 | -9.53 Million USD | 45.84% |
| 2012 Q1 | -584 Thousand USD | -209.81% |
| 2012 FY | -42.22 Million USD | -1130.28% |
| 2011 Q4 | 531.84 Thousand USD | -70.22% |
| 2011 FY | 4.09 Million USD | 247.68% |
| 2011 Q2 | 1.57 Million USD | 659.9% |
| 2011 Q1 | 207 Thousand USD | 103.45% |
| 2011 Q3 | 1.78 Million USD | 13.54% |
| 2010 Q4 | -6 Million USD | -755.44% |
| 2010 Q1 | 1.13 Million USD | 184.96% |
| 2010 Q2 | 1.17 Million USD | 3.79% |
| 2010 Q3 | 916 Thousand USD | -22.24% |
| 2010 FY | -2.77 Million USD | -141.46% |
| 2009 Q4 | 398.3 Thousand USD | -58.85% |
| 2009 FY | 6.69 Million USD | 104.68% |
| 2009 Q1 | 3.03 Million USD | 101.88% |
| 2009 Q2 | 2.29 Million USD | -24.51% |
| 2009 Q3 | 968 Thousand USD | -57.77% |
| 2008 Q4 | -161.33 Million USD | -2714.43% |
| 2008 FY | -142.94 Million USD | -681.56% |
| 2008 Q3 | 6.17 Million USD | -3.14% |
| 2008 Q2 | 6.37 Million USD | 8.91% |
| 2008 Q1 | 5.85 Million USD | -19.5% |
| 2007 Q2 | 5.46 Million USD | 13.72% |
| 2007 Q4 | 7.26 Million USD | 3.1% |
| 2007 Q1 | 4.8 Million USD | -36.07% |
| 2007 Q3 | 7.04 Million USD | 29.08% |
| 2007 FY | 24.57 Million USD | 47.75% |
| 2006 FY | 16.63 Million USD | 12.77% |
| 2006 Q4 | 7.51 Million USD | 6056.88% |
| 2006 Q1 | 4.57 Million USD | -6.46% |
| 2006 Q2 | 4.43 Million USD | -3.0% |
| 2006 Q3 | 122 Thousand USD | -97.25% |
| 2005 Q1 | 3.63 Million USD | -34.73% |
| 2005 FY | 14.75 Million USD | -28.59% |
| 2005 Q2 | 1.24 Million USD | -65.65% |
| 2005 Q3 | 4.98 Million USD | 298.88% |
| 2005 Q4 | 4.88 Million USD | -1.94% |
| 2004 FY | 20.65 Million USD | -19.99% |
| 2004 Q2 | 5.09 Million USD | 4.94% |
| 2004 Q3 | 5.13 Million USD | 0.73% |
| 2004 Q4 | 5.57 Million USD | 8.51% |
| 2004 Q1 | 4.85 Million USD | -5.45% |
| 2003 Q2 | 6.83 Million USD | -3.13% |
| 2003 Q3 | 6.8 Million USD | -0.4% |
| 2003 Q4 | 5.13 Million USD | -24.49% |
| 2003 FY | 25.82 Million USD | -13.3% |
| 2003 Q1 | 7.05 Million USD | -20.61% |
| 2002 Q2 | 8.03 Million USD | 14.79% |
| 2002 Q3 | 5.87 Million USD | -26.89% |
| 2002 Q1 | 6.99 Million USD | 237.04% |
| 2002 FY | 29.78 Million USD | 243.43% |
| 2002 Q4 | 8.88 Million USD | 51.26% |
| 2001 FY | 8.67 Million USD | 88.6% |
| 2001 Q2 | 1.33 Million USD | 0.0% |
| 2001 Q1 | 1.33 Million USD | 0.0% |
| 2001 Q3 | 3.92 Million USD | 193.31% |
| 2001 Q4 | 2.07 Million USD | -47.07% |
| 2000 FY | 4.59 Million USD | -60.17% |
| 1999 FY | 11.54 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 435.215% |
| Addus HomeCare Corporation | 62.51 Million USD | -16.18% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | 1721.59% |
| Amedisys, Inc. | -9.74 Million USD | 845.163% |
| Astrana Health, Inc. | 60.71 Million USD | -19.622% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 153.991% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 3.31 Million USD | -2090.32% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 862.797% |
| COMPASS Pathways plc | -118.46 Million USD | 161.311% |
| DocGo Inc. | 6.85 Million USD | -958.999% |
| The Ensign Group, Inc. | 209.39 Million USD | 65.315% |
| Healthcare Services Group, Inc. | 38.38 Million USD | -89.212% |
| InnovAge Holding Corp. | -21.33 Million USD | 440.383% |
| The Joint Corp. | -9.75 Million USD | 844.766% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 138.994% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 565.5% |
| ModivCare Inc. | -204.46 Million USD | 135.523% |
| NewGenIvf Group Limited | 130.19 Thousand USD | -55687.177% |
| Option Care Health, Inc. | 267.09 Million USD | 72.807% |
| P3 Health Partners Inc. | -57.77 Million USD | 225.718% |
| P3 Health Partners Inc. | -57.77 Million USD | 225.718% |
| The Pennant Group, Inc. | 13.37 Million USD | -442.873% |
| Surgery Partners, Inc. | -11.9 Million USD | 710.345% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | 2571.835% |
| Talkspace, Inc. | -19.18 Million USD | 478.641% |
| Talkspace, Inc. | -19.18 Million USD | 478.641% |
| The Oncology Institute, Inc. | -83.06 Million USD | 187.436% |
| The Oncology Institute, Inc. | -83.06 Million USD | 187.436% |